FR3068605B1 - Composition pour le traitement et/ou la prevention des symptomes du bas appareil urinaire - Google Patents

Composition pour le traitement et/ou la prevention des symptomes du bas appareil urinaire Download PDF

Info

Publication number
FR3068605B1
FR3068605B1 FR1770739A FR1770739A FR3068605B1 FR 3068605 B1 FR3068605 B1 FR 3068605B1 FR 1770739 A FR1770739 A FR 1770739A FR 1770739 A FR1770739 A FR 1770739A FR 3068605 B1 FR3068605 B1 FR 3068605B1
Authority
FR
France
Prior art keywords
composition
prevention
treatment
lower urinary
urinary symptoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1770739A
Other languages
English (en)
Other versions
FR3068605A1 (fr
Inventor
Sossio MORRA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AXEEN PHARMA, MC
Original Assignee
Serelys Pharma S A M
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serelys Pharma S A M filed Critical Serelys Pharma S A M
Priority to FR1770739A priority Critical patent/FR3068605B1/fr
Publication of FR3068605A1 publication Critical patent/FR3068605A1/fr
Application granted granted Critical
Publication of FR3068605B1 publication Critical patent/FR3068605B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/42—Cucurbitaceae (Cucumber family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

L'invention concerne une composition pour son utilisation dans le traitement et/ou la prévention des symptômes du bas appareil urinaire (SBAU). L'invention se caractérise en ce que la composition comprend un extrait huileux et un extrait aqueux de pollen, un extrait de graines de plante(s) appartenant au genre Cucurbita et de la vitamine E ou ses esters.
FR1770739A 2017-07-10 2017-07-10 Composition pour le traitement et/ou la prevention des symptomes du bas appareil urinaire Active FR3068605B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1770739A FR3068605B1 (fr) 2017-07-10 2017-07-10 Composition pour le traitement et/ou la prevention des symptomes du bas appareil urinaire

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1770739A FR3068605B1 (fr) 2017-07-10 2017-07-10 Composition pour le traitement et/ou la prevention des symptomes du bas appareil urinaire
FR1770739 2017-07-10

Publications (2)

Publication Number Publication Date
FR3068605A1 FR3068605A1 (fr) 2019-01-11
FR3068605B1 true FR3068605B1 (fr) 2020-02-21

Family

ID=60081088

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1770739A Active FR3068605B1 (fr) 2017-07-10 2017-07-10 Composition pour le traitement et/ou la prevention des symptomes du bas appareil urinaire

Country Status (1)

Country Link
FR (1) FR3068605B1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230149498A1 (en) * 2019-01-18 2023-05-18 Sérélys Pharma S.A.M. Composition for the treatment and/or prevention of lower urinary tract symptoms

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230149498A1 (en) * 2019-01-18 2023-05-18 Sérélys Pharma S.A.M. Composition for the treatment and/or prevention of lower urinary tract symptoms

Also Published As

Publication number Publication date
FR3068605A1 (fr) 2019-01-11

Similar Documents

Publication Publication Date Title
MA44659B1 (fr) Anticorps anti-tim-3 et compositions
MA55434B1 (fr) Compositions comprenant des souches bactériennes
MA41010A (fr) Compositions comprenant des souches bactériennes
AR106768A1 (es) Composiciones que comprenden cepas bacterianas
MA40290A1 (fr) Agents immunorégulateurs
PH12017501841A1 (en) Method for discriminating symptom of hepatic disease
MA42376B1 (fr) Dérivés d'oxopyridine substitués
MA35039B1 (fr) Dérivés ramifiés de l'acide 3-phénylpropionique et leur utilisation
FR3021970B1 (fr) Anticorps dirige contre la galectine 9 et inhibiteur de l'activite suppressive des lymphocytes t regulateurs
MA35920B1 (fr) Composés destinés au traitement de l'amyotrophie spinale
MA35638B1 (fr) 2-thiopyrimidinones
MA38349A1 (fr) Œstra-1,3,5(10),16-tétraéno-3-carboxamide pour inhiber la 17-bêta-hydroxystéroïde déshydrogénase (akr1c3)
MA38810A1 (fr) Inhibiteurs de rorc2 méthodes d'utilisation associées
MA38688B1 (fr) Composition solide pour administration orale contenant de l'acide ibandronique ou un sel pharmaceutiquement acceptable de celui-ci et de la vitamine d
MA38925B1 (fr) Dérivés de phénylalanine substitués
FR3053253B1 (fr) Nouvel extrait d'akenes de silybum marianum et ses utilisations en dermatologie et dermo-cosmetique
FR3007039B1 (fr) Procede d'obtention d'un extrait de plante et compositions associees
FR3068605B1 (fr) Composition pour le traitement et/ou la prevention des symptomes du bas appareil urinaire
FR3070263B1 (fr) Composition pour son utilisation dans le traitement et/ou la prevention de l’infertilite
FR3069413B1 (fr) Extrait hydrosoluble de propolis, procede d'obtention et utilisation pour prevenir et/ou lutter contre les maladies des vegetaux
EA201700052A1 (ru) Применение в одной пилюле, таблетке, капсуле миноциклина, ациклогуанозина, аторвастатина и витамина d для лечения ревматоидного артрита
FR3091819B1 (fr) Composition pour le traitement et/ou la prevention des symptomes du bas appareil urinaire
MX2021001333A (es) Composiciones y metodos para tratar disfuncion sexual y aumentar la respuesta y placer sexual.
FR3088195B1 (fr) Extrait d'algues rouges pour son utilisation pour la prevention ou le traitement d'un trouble intestinal
FR3059236B1 (fr) Extraits de plantes du genre tagetes et leurs utilisations

Legal Events

Date Code Title Description
PLSC Publication of the preliminary search report

Effective date: 20190111

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

TP Transmission of property

Owner name: AXEEN PHARMA, MC

Effective date: 20230110

PLFP Fee payment

Year of fee payment: 7

RM Correction of a material error

Effective date: 20230630

PLFP Fee payment

Year of fee payment: 8